Cargando…
Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
BACKGROUND: In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. However, data are limited on complication...
Autores principales: | Saito, Yuichi, Tateishi, Kazuya, Toda, Koichi, Matsumiya, Goro, Kobayashi, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547360/ https://www.ncbi.nlm.nih.gov/pubmed/37646217 http://dx.doi.org/10.1161/JAHA.123.030819 |
Ejemplares similares
-
Impella versus IABP in acute myocardial infarction complicated by cardiogenic
shock
por: Alushi, Brunilda, et al.
Publicado: (2019) -
Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019) -
Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022) -
Prognostic Factors of In-Hospital Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Sato, Takanori, et al.
Publicado: (2022) -
Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)